Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Webcast

Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference


Revance Therapeutics, Inc. (RVNC), today announced that the company will be participating in the Guggenheim Healthcare Talks, 6th Annual Biotechnology Conference, taking place February 7-8, 2024, in New York, New York. Chief Executive Officer, Mark J. Foley, is scheduled to participate in a fireside chat on Thursday, February 8, at 9:30a.m. EST.

Interested parties can access the live audio webcast for this conference from the Investor Relations section of the company's website at www.revance.com. The webcast replay will be available after the conclusion of the live presentation for approximately 90 days.

About Revance

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences. Revance's portfolio includes DAXXIFY (daxibotulinumtoxinA-lanm) for injection and the RHA Collection of dermal fillers in the U.S. Revance has also partnered with Viatris Inc. to develop a biosimilar to onabotulinumtoxinA for injection and Shanghai Fosun Pharmaceutical to commercialize DAXXIFY in China.

Revance is headquartered in Nashville, Tenn., with additional office locations in Newark and Irvine, Calif. Learn more at www.Revance.com, www.RevanceAesthetics.com, www.DAXXIFY.com, https://hcp.daxxifytherapy.com/, or connect with us on LinkedIn.

"Revance", the Revance logo, and DAXXIFY are registered trademarks of Revance Therapeutics, Inc. Resilient Hyaluronic Acid® and RHA are trademarks of TEOXANE SA.


These press releases may also interest you

at 14:48
Methodist North Hospital once again earns prestigious Magnet® Designation
Methodist Le Bonheur Healthcare today announced Methodist North Hospital once again earned Magnet Designation by the American Nurses Credentialing Center (ANCC), reaffirming its status as the only adult hospital in West Tennessee recognized for...

at 14:41
Orchard Software's Solutions Provide Support for Labs That Perform LDTs, Now Under FDA Oversight
In response to the April 29th U.S. Food & Drug Administration (FDA) Final Rule 21 CFR Part 809 Medical Devices: Laboratory Developed Tests (LDTs), Orchard Software is actively working alongside its customers to fully understand the implications and...

at 14:10
Mental Health Awareness Month Highlights Connection Between Gambling Disorder and Mental Wellness
As the world acknowledges the importance of addressing mental health topics, new data from Ohio for Responsible Gambling (ORG) shows how gambling disorders can have wide-ranging impacts on those who gamble and the community around them. "There's a...

at 14:07
2 People Injured in Truck Accident on S.H. 302 in Odessa
Grossman Law Offices, with its principal office in Dallas, TX, extends its support to the individuals involved in a two-truck accident that occurred on April 3, 2024, around 9:30 a.m. along State Highway 302 in Ector County, TX. Two people sustained...

at 14:00
Allergy and Asthma Experts Prepare for Air Quality Awareness Week
May 6 - 10 is Air Quality Awareness Week, and experts in the allergy/immunology field are addressing the impact of air quality on public health. The effects of climate change, air pollution and other environmental factors can cause unique challenges...

at 14:00
HiPaaS launches its 'Make AI Real' capability to help healthcare companies implement AI solutions for patient care and to simplify administration.
HiPaaS Inc, a leading healthcare technology firm, is excited to unveil its 'Make AI Real' capabilities. This initiative aims to help healthcare companies implement Artificial...

More news about Health...


News published on and distributed by: